I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45 SEK 0.78% Market Closed
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

InDex Pharmaceuticals Holding AB
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InDex Pharmaceuticals Holding AB
Revenue Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
MOB

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Revenue
kr100k
CAGR 3-Years
123%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Revenue
kr1.6B
CAGR 3-Years
1 488%
CAGR 5-Years
63%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Revenue
kr1.6B
CAGR 3-Years
50%
CAGR 5-Years
94%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Revenue
kr2.5B
CAGR 3-Years
75%
CAGR 5-Years
85%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Revenue
kr5.7m
CAGR 3-Years
N/A
CAGR 5-Years
216%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Revenue
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is InDex Pharmaceuticals Holding AB's Revenue?
Revenue
100k SEK

Based on the financial report for Jun 30, 2024, InDex Pharmaceuticals Holding AB's Revenue amounts to 100k SEK.

What is InDex Pharmaceuticals Holding AB's Revenue growth rate?
Revenue CAGR 5Y
0%

Over the last year, the Revenue growth was -100%. The average annual Revenue growth rates for InDex Pharmaceuticals Holding AB have been 123% over the past three years .

Back to Top